Precision medicine, AI, and the future of personalized health care

KB Johnson, WQ Wei, D Weeraratne… - Clinical and …, 2021 - Wiley Online Library
The convergence of artificial intelligence (AI) and precision medicine promises to
revolutionize health care. Precision medicine methods identify phenotypes of patients with …

Neuropilin-1: a key protein to consider in the progression of pediatric brain tumors

M Douyère, P Chastagner, C Boura - Frontiers in Oncology, 2021 - frontiersin.org
Neuropilins are transmembrane glycoproteins that play important roles in cardiovascular
and neuronal development, as well as in immunological system regulations. NRP1 functions …

Rapid discrimination of pediatric brain tumors by mass spectrometry imaging

AR Clark, D Calligaris, MS Regan… - Journal of Neuro …, 2018 - Springer
Purpose Medulloblastoma, the most common primary pediatric malignant brain tumor,
originates in the posterior fossa of the brain. Pineoblastoma, which originates within the …

Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes

H Weishaupt, P Johansson, A Sundström… - …, 2019 - academic.oup.com
Motivation Medulloblastoma (MB) is a brain cancer predominantly arising in children.
Roughly 70% of patients are cured today, but survivors often suffer from severe sequelae …

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma

Y Cormerais, M Pagnuzzi‐Boncompagni… - Journal of Cellular …, 2019 - Wiley Online Library
Most cases of medulloblastoma (MB) occur in young children. While the overall survival rate
can be relatively high, current treatments combining surgery, chemo‐and radiotherapy are …

Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death

L Kallay, H Keskin, A Ross, M Rupji, OA Moody… - Journal of neuro …, 2019 - Springer
Purpose Pediatric brain cancer medulloblastoma (MB) standard-of-care results in numerous
comorbidities. MB is comprised of distinct molecular subgroups. Group 3 molecular …

Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level

S Godbole, H Voß, A Gocke, S Schlumbohm… - Nature …, 2024 - nature.com
Medulloblastomas (MBs) are malignant pediatric brain tumors that are molecularly and
clinically heterogenous. The application of omics technologies—mainly studying nucleic …

Thioredoxin system protein expression is associated with poor clinical outcome in adult and paediatric gliomas and medulloblastomas

A Yao, SJ Storr, K Al-Hadyan, R Rahman, S Smith… - Molecular …, 2020 - Springer
The thioredoxin (Trx) system is an important enzyme family that regulates cellular redox
homeostasis. Protein expression of Trx system family members has been assessed in …

Molecular genetics of medulloblastoma in children: diagnostic, therapeutic and prognostic implications

ME Doussouki, A Gajjar, O Chamdine - Future Neurology, 2019 - Taylor & Francis
Medulloblastoma is the most common embryonal tumor in children. The current standard of
care comprises surgical resection, radiation and chemotherapy. Patients are stratified into …

Molecular targeted therapies: time for a paradigm shift in medulloblastoma treatment?

L Gatto, E Franceschi, A Tosoni, V Di Nunno… - Cancers, 2022 - mdpi.com
Simple Summary In the last decade, medulloblastoma entered the molecular era, with
progressive advances in the knowledge of the molecular biology of this rare tumor. These …